Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. (Q43654252)

25 November 2017

Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. (English)

1 reference

25 November 2017

Waite DC

1

1 reference

25 November 2017

Jacobson EW

2

1 reference

25 November 2017

Ennis FA

3

1 reference

25 November 2017

Edelman R

4

1 reference

25 November 2017

White B

5

1 reference

25 November 2017

Kammer R

6

1 reference

25 November 2017

Anderson C

7

1 reference

25 November 2017

Kensil CR

8

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

19

1 reference

25 November 2017

28-29

1 reference

25 November 2017

3957-3967

1 reference

Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Comparison of the effect of different immunological adjuvants on the antibody and T-cell response to immunization with MUC1-KLH and GD3-KLH conjugate cancer vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

QS-21: a water-soluble triterpene glycoside adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Current perspectives on pain upon injection of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Local tolerance of subcutaneous injections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Determination of deltoid fat pad thickness. Implications for needle length in adult immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Benzyl alcohol attenuates the pain of lidocaine injections and prolongs anesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

"Inactive" Ingredients in Pharmaceutical Products: Update (Subject Review)

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

Benzyl alcohol as an alternative local anesthetic.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900142-6

7 January 2021

10.1016/S0264-410X(01)00142-6

Identifiers

DOI

1 reference

25 November 2017

1 reference